University of Pennsylvania and Syracuse University scientists have discovered that a hindbrain-derived peptide, octadecaneuropeptide (ODN), can suppress appetite and improve glucose regulation without ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

(1276.HK; 600276.SH) delivered a piece of good news for investors with positive trial data for a dual-acting obesity drug ...

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...

In India’s rapidly urbanising metros, from Delhi to Bengaluru, life moves fast. Unfortunately, so do lifestyle-related ...

Menopause can feel like one big balancing act. Between managing your hormone levels and symptoms like hot flashes, night ...

Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...

With global demand for GLP-1-based drugs rising, Indian CDMOs are ramping up peptide capabilities ahead of key patent ...

“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...

British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs to curb their off-label use for weight loss and preserve supply for people who are diabetic.

Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...

Both GLP-1 drugs, semaglutide is the active ingredient in popular weight-loss drug found in Ozempic and Wegovy, while tirzepatide can be found in Mounjaro and Zepbound.